We next used the xenograft AML mouse model to determine whether the effects of BAY 2666605 on SLFN12 stabilization and changes in gene expression in vivo correlate with differences in leukemic cell growth and survival (Fig. 6A). Here, SLFN12 is linked to acute myeloid leukemia.